Interaction effects between angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID‐19: A population‐based study
Jiandong Zhou, Gary Tse, Sharen Lee, Tong Liu, Zhidong Cao, Daniel Zeng, Keith Sai Kit Leung, Abraham Ka Chung Wai, Ian Chi Kei Wong, Bernard Man Yung Cheung, Qingpeng Zhang
Abstract
The peer review history for this article is available at https://publons.com/publon/10.1002/jmv.26904. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Angiotensin-converting enzyme 2VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Renin–angiotensin systemAngiotensin Receptor Blockers2019-20 coronavirus outbreakEnzymeAngiotensin IIPopulationReceptorPharmacologyMedicineInternal medicineBiologyBiochemistryEnvironmental healthBlood pressureDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Impact on Reproduction